Study to Evaluate the Safety of Nanoxel M Inj.

Clinical trial NCT04066335 · UNKNOWN

Trial details

NCT number: NCT04066335
Sponsor: Samyang Biopharmaceuticals Corporation
Status: UNKNOWN
Study type: OBSERVATIONAL

Breast Cancer Non-small Cell Lung Cancer Prostate Cancer Ovarian Cancer Head and Neck Cancer Gastric Cancer Esophageal Cancer

Start date: 2019-09-18
Primary completion: 2024-08-01
Enrollment: 1498

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.